Clinical Trial Update: rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for rESP, evaluating tolerability, safety, and pharmacokinetics after a single intravenous dose with dose escalation in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• rESP

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Chronic Renal Failure | Phase 1 | Status: UNKNOWN